Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
24
Number of overlapping holdings
20.3%
% of XBI's 119 holdings also in CNCR
37.5%
% of CNCR's 64 holdings also in XBI
Overlap by Weight
Sector Drift (XBI minus CNCR)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in XBI |
Weight in CNCR |
Overlap | |
|---|---|---|---|---|
 |
EXELIXIS INC | 2.1% | 1.8% | 1.8% |
|
BLUEPRINT MEDICINES CORP. | 2.2% | 1.7% | 1.7% |
|
REVOLUTION MEDICINES, INC. | 1.5% | 1.7% | 1.5% |
|
REGENERON PHARMACEUTICALS | 2.3% | 1.5% | 1.5% |
|
SUMMIT THERAPEUTICS INC | 1.4% | 2.2% | 1.4% |
Position Highlights (Non-Overlapping Exposures)
XBI Overweight Relative to CNCR
|
NATERA INC | 2.8% |
|
VERTEX PHARMACEUTICALS INC | 2.7% |
|
INSMED INC | 2.7% |
|
ALNYLAM PHARMACEUTICALS INC | 2.7% |
|
NEUROCRINE BIOSCIENCES INC | 2.6% |
|
UNITED THERAPEUTICS CORP | 2.6% |
|
GILEAD SCIENCES INC | 2.5% |
|
EXACT SCIENCES CORP | 2.5% |
|
AMGEN INC | 2.5% |
|
INCYTE CORP | 2.4% |
XBI Underweight Relative to CNCR
|
FATE THERAPEUTICS INC | -2.1% |
|
SCHRODINGER, INC. | -2.0% |
|
GINKGO BIOWORKS HOLDINGS INC CLASS A | -1.8% |
|
2SEVENTY BIO, INC. | -1.8% |
|
ARVINAS, INC. | -1.8% |
|
Y-MABS THERAPEUTICS, INC. | -1.8% |
 |
BIONTECH SE SPONSORED ADR | -1.8% |
 |
GENMAB A/S SPONSORED ADR | -1.7% |
 |
IMMUNOCORE HOLDINGS PLC SPONSORED AD | -1.7% |
|
NUVATION BIO INC CLASS A | -1.7% |